Abbonarsi

Cardiac arrhythmias and electrophysiologic responses during spontaneous hyperglycaemia in adults with type 1 diabetes mellitus - 02/11/21

Doi : 10.1016/j.diabet.2021.101237 
A. Bernjak a, b, 1, P. Novodvorsky a, c, 1, E. Chow c, d, 2, A. Iqbal a, c, d, L. Sellors a, c, S. Williams a, c, R.A. Fawdry a, c, J.L.B. Marques a, 3, R.M. Jacques e, M.J. Campbell e, P.J. Sheridan c, d, S.R. Heller a, c,
a Department of Oncology & Metabolism, University of Sheffield, Sheffield, United Kingdom 
b INSIGNEO Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom 
c Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom 
d Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom 
e School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom 

Corresponding author at: Department of Oncology & Metabolism, University of Sheffield, Medical School, Beech Hill Road, Sheffield, S10 2RX, United Kingdom.Department of Oncology & MetabolismUniversity of SheffieldMedical SchoolBeech Hill RoadSheffieldS10 2RXUnited Kingdom

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

Spontaneous hyperglycaemia didn’t prolong QTc interval in people with T1DM and without history of cardiovascular disease.
Cardiac arrhythmias were uncommon and confined to bradycardia and ectopic beats.
There was considerable diurnal and inter-subject variability in the incidences of arrhythmias.
Reassuringly, hyperglycaemia wasn’t linked with clinically relevant arrhythmias.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Aim

We examined the effect of spontaneous hyperglycaemia in adults with type 1 diabetes mellitus (T1DM) and without history of cardiovascular disease on heart rate variability (HRV), cardiac repolarisation and incidence of cardiac arrhythmias.

Methods

Thirty-seven individuals with T1DM (age 17–50 years, 19 males, mean duration of diabetes 19.3 SD(9.6) years) underwent 96 h of simultaneous ambulatory 12-lead Holter ECG and blinded continuous interstitial glucose (IG) monitoring (CGM). HRV, QT interval and cardiac repolarisation were assessed during hyperglycaemia (IG ≥ 15 mmol/l) and compared with matched euglycaemia (IG 5−10 mmol/l) on a different day, separately during the day and night. Rates of arrhythmias were assessed by calculating incidence rate differences.

Results

Simultaneous ECG and CGM data were recorded for 2395 hours. During daytime hyperglycaemia vs euglycaemia the mean QTc interval duration was 404 SD(21)ms vs 407 SD(20)ms, P = 0.263. T-peak to T-end interval duration corrected for heart rate (TpTendc) shortened: 74.8 SD(16.1)ms vs 79.0 SD(14.8)ms, P = 0.033 and T-wave symmetry increased: 1.62 SD(0.33) vs 1.50 SD(0.39), P = 0.02. During night-time hyperglycaemia vs euglycaemia, the mean QTc interval duration was 401 SD(26)ms vs 404 SD(27)ms, P = 0.13 and TpTend shortened: 62.4 SD(12.0)ms vs 67.1 SD(11.8)ms, P = 0.003. The number of cardiac arrhythmias was low and confined to bradycardia and isolated ectopic beats. A considerable inter-subject and diurnal variability was observed.

Conclusions

Hyperglycaemia in individuals with T1DM without known cardiovascular disease was not associated with clinically important cardiac arrhythmias.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Cardiac arrhythmias, Cardiac electrophysiology, Heart rate variability (HRV), Hyperglycaemia, QTc interval, Type 1 diabetes mellitus (T1DM)


Mappa


© 2021  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 47 - N° 5

Articolo 101237- Settembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes
  • Mark M. Smits, Kristina S. Fluitman, Hilde Herrema, Mark Davids, Mark H.H. Kramer, Albert K. Groen, Clara Belzer, Willem M. de Vos, Djuna L. Cahen, Max Nieuwdorp, Daniël H. van Raalte
| Articolo seguente Articolo seguente
  • Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function
  • Saijun Zhou, YuLing Zhang, TongDan Wang, Shuai Huang, Siyi Gong, Junmei Wang, Pei Yu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.